Cargando…

Differential prognostic utility of NTproBNP and Cystatin C in patients with acute exacerbation of chronic pulmonary disease

OBJECTIVES: To determine whether serum Cystatin C (CysC) and NTproBNP have prognostic value among patients with long-standing chronic lung disease. DESIGN: Prospective, observational, non-interventional study. SETTING: CysC and NTproBNP are prognostic markers in several cardiac conditions. In additi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Calvo, Juan I, Sánchez-Marteles, Marta, Ruiz-Ruiz, Francisco-José, Morales-Rull, José-Luis, Nieto-Rodríguez, José-Antonio
Formato:	Texto
Lenguaje:	English
Publicado:	Royal Society of Medicine Press 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984364/ https://www.ncbi.nlm.nih.gov/pubmed/21103136 http://dx.doi.org/10.1258/shorts.2010.010059

Ejemplares similares

Effects of enalaprilat sodium on plasma NTproANP and NTproBNP levels in healthy volunteers
por: Heringlake, M, et al.
Publicado: (2006)

The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart disease
por: Heringlake, M, et al.
Publicado: (2009)

Short term variation in NTproBNP after lifestyle intervention in severe obesity
por: Fedele, Debora, et al.
Publicado: (2017)

Pregnancy in a healthy population: dynamics of NTproBNP and hs-cTroponin T
por: Furenäs, Eva, et al.
Publicado: (2020)

Doppler Echocardiography Combined with NTproBNP/BNP in the Diagnosis of Pulmonary Artery Hypertension Associated with Congenital Heart Disease
por: Zhang, Xi, et al.
Publicado: (2023)

Brain-derived neurotrophic factor is related with adverse cardiac remodeling and high NTproBNP
por: Bahls, Martin, et al.
Publicado: (2019)

The effects of variations in thoracic blood volume and intravenous sodium loading on plasma levels of NTproANP and NTproBNP in healthy volunteers
por: Heringlake, M, et al.
Publicado: (2004)

NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study
por: Baldassarre, Stefano, et al.
Publicado: (2017)

Reduced left atrial contractile strain with speckle tracking analysis predicts abnormal plasma NTproBNP in an asymptomatic community population
por: Liu, Lin, et al.
Publicado: (2022)

Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study
por: Kruzan, Rachel M., et al.
Publicado: (2016)

The Effect of Synbiotic Consumption on Serum NTproBNP, hsCRP and Blood Pressure in Patients With Chronic Heart Failure: A Randomized, Triple-Blind, Controlled Trial
por: Shoaei Matin, Shakiba, et al.
Publicado: (2022)

Early N-Terminal Pro B-Type Natriuretic Peptide (NTproBNP) Plasma Values and Associations with Patent Ductus Arteriosus Closure and Treatment—An Echocardiography Study of Extremely Preterm Infants
por: Gudmundsdottir, Anna, et al.
Publicado: (2022)

Optimal screening of heart failure patients: tissue Doppler imaging or plasma NTpro BNP measurement?
por: Baur, Leo H. B.
Publicado: (2008)

Prognostic Usefulness of Basic Analytical Data in Chronic Obstructive Pulmonary Disease Exacerbation
por: Martínez-Gestoso, Sandra, et al.
Publicado: (2023)

PREDICTIVE VALUE OF TROPONIN, NTPROBNP AND SODIUM ON ADVERSE CLINICAL OUTCOMES IN COVID-19
por: Roman, Aida, et al.
Publicado: (2021)

Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis
por: Wang, Qing-ping, et al.
Publicado: (2013)

Correction: Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis
por: Wang, Qing-ping, et al.
Publicado: (2013)

N-Terminal pro C-Type Natriuretic Peptide (NTproCNP) and myocardial function in ageing
por: Keng, Bryan M. H., et al.
Publicado: (2018)

The alteration of NTproCNP plasma levels following anaerobic exercise in physically active young men
por: Temür, Hilal Akseki, et al.
Publicado: (2015)

Prognostic Implications of Chronic Heart Failure and Utility of NT-proBNP Levels in Heart Failure Patients with SARS-CoV-2 Infection
por: Belarte-Tornero, Laia C., et al.
Publicado: (2021)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD
por: Li, Haiqing, et al.
Publicado: (2020)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
Publicado: (2020)

NT-proBNP predicts the need for ventilatory support in the patients with acute exacerbation of chronic obstructive pulmonary disease
por: Kuharic, J, et al.
Publicado: (2015)

The serum creatinine to cystatin C ratio predicts the risk of acute exacerbation of chronic obstructive pulmonary disease
por: He, Liang, et al.
Publicado: (2023)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study
por: Rodriguez Hermosa, Juan Luis, et al.
Publicado: (2020)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
por: Linssen, G. C. M., et al.
Publicado: (2018)

Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease
por: Santibáñez, Miguel, et al.
Publicado: (2016)

NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease
por: Martínez-Milla, Juan, et al.
Publicado: (2022)

Can NT-pro BNP Levels Predict Prognosis of Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?
por: Ediboğlu, Özlem, et al.
Publicado: (2018)

The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
por: Campbell, Ross T., et al.
Publicado: (2020)

Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Cardio-Renal Anemia Syndrome　― Difference in Prognostic Ability ―
por: Otaki, Yoichiro, et al.
Publicado: (2019)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
por: Sweeney, Claire, et al.
Publicado: (2021)

Direct Immunochemiluminescent Assay for proBNP and Total BNP in Human Plasma proBNP and Total BNP Levels in Normal and Heart Failure
por: Nishikimi, Toshio, et al.
Publicado: (2013)

Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease
por: Lacoma, Alicia, et al.
Publicado: (2011)

Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
por: Costa-Rodríguez, Noelia, et al.
Publicado: (2023)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations
por: Avriel, Avital, et al.
Publicado: (2016)

Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Huang, Dan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ul1bo4ao512kg3j4agaacuotm